Free Trial

Banque Cantonale Vaudoise Purchases New Holdings in Teladoc Health, Inc. (NYSE:TDOC)

Teladoc Health logo with Medical background

Banque Cantonale Vaudoise purchased a new position in Teladoc Health, Inc. (NYSE:TDOC - Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 102,825 shares of the health services provider's stock, valued at approximately $1,553,000. Banque Cantonale Vaudoise owned about 0.06% of Teladoc Health at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the stock. Avondale Wealth Management bought a new position in shares of Teladoc Health in the first quarter worth about $121,000. Nomura Holdings Inc. bought a new position in Teladoc Health during the 4th quarter worth about $220,000. Vanguard Group Inc. grew its holdings in Teladoc Health by 11.8% during the 4th quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider's stock worth $377,451,000 after acquiring an additional 1,855,480 shares in the last quarter. ICA Group Wealth Management LLC bought a new position in Teladoc Health during the 4th quarter worth about $28,000. Finally, Spouting Rock Asset Management LLC grew its holdings in Teladoc Health by 13.5% during the 4th quarter. Spouting Rock Asset Management LLC now owns 39,100 shares of the health services provider's stock worth $843,000 after acquiring an additional 4,660 shares in the last quarter. 76.82% of the stock is currently owned by institutional investors.

Teladoc Health Stock Performance

Shares of Teladoc Health stock traded up $0.06 during midday trading on Friday, hitting $9.71. The company had a trading volume of 11,422,831 shares, compared to its average volume of 3,975,549. Teladoc Health, Inc. has a 12-month low of $9.59 and a 12-month high of $30.41. The company has a quick ratio of 3.74, a current ratio of 3.82 and a debt-to-equity ratio of 0.67. The stock has a market cap of $1.65 billion, a price-to-earnings ratio of -6.89 and a beta of 0.99. The company has a fifty day simple moving average of $11.89 and a 200 day simple moving average of $16.06.


Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.47) by ($0.02). Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.90%. The business had revenue of $646.13 million for the quarter, compared to analysts' expectations of $637.31 million. During the same period in the prior year, the business posted ($0.37) earnings per share. The business's quarterly revenue was up 2.7% compared to the same quarter last year. As a group, analysts predict that Teladoc Health, Inc. will post -1.05 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have issued reports on TDOC shares. Leerink Partnrs reiterated a "market perform" rating on shares of Teladoc Health in a report on Monday, February 26th. Evercore ISI dropped their target price on shares of Teladoc Health from $15.00 to $14.00 and set an "in-line" rating on the stock in a report on Friday, April 26th. Barclays dropped their target price on shares of Teladoc Health from $25.00 to $20.00 and set an "overweight" rating on the stock in a report on Friday, April 26th. Truist Financial lowered their price target on shares of Teladoc Health from $23.00 to $17.00 and set a "hold" rating on the stock in a report on Wednesday, March 6th. Finally, Stifel Nicolaus lowered their price target on shares of Teladoc Health from $21.00 to $16.00 and set a "hold" rating on the stock in a report on Friday, April 26th. Thirteen equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $18.22.

Check Out Our Latest Research Report on TDOC

Insiders Place Their Bets

In other Teladoc Health news, Director Karen L. Daniel sold 9,834 shares of the firm's stock in a transaction that occurred on Thursday, May 23rd. The shares were sold at an average price of $11.90, for a total transaction of $117,024.60. Following the completion of the transaction, the director now directly owns 36,995 shares of the company's stock, valued at approximately $440,240.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other news, Director Karen L. Daniel sold 9,834 shares of Teladoc Health stock in a transaction that occurred on Thursday, May 23rd. The shares were sold at an average price of $11.90, for a total transaction of $117,024.60. Following the completion of the transaction, the director now directly owns 36,995 shares of the company's stock, valued at approximately $440,240.50. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Laizer Kornwasser sold 10,411 shares of Teladoc Health stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $12.69, for a total transaction of $132,115.59. Following the transaction, the insider now directly owns 86,070 shares of the company's stock, valued at $1,092,228.30. The disclosure for this sale can be found here. In the last ninety days, insiders sold 39,650 shares of company stock valued at $505,863. 0.95% of the stock is owned by insiders.

Teladoc Health Profile

(Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

See Also

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Should you invest $1,000 in Teladoc Health right now?

Before you consider Teladoc Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.

While Teladoc Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Top Market Leaders Splitting Their Stocks
How to Navigate Stock Downgrades
CPI News Breakdown: Key Market Moves to Follow

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines